Phytobacterium plantarum LPU3 and application thereof in relieving hyperuricemia
By developing a combination of Lactobacillus plantarum LPU3 and its inactivated, dead, and postbiotic cells, the problems of single function and stability of existing strains have been solved, achieving multiple effects of uric acid regulation and intestinal improvement, and enhancing the stability and safety of the product.
Patent Information
- Application Number
- CN202610320537.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-17
- Publication Date
- 2026-06-09
AI Technical Summary
Existing strains of *Lactobacillus plantarum* have single functional targets for uric acid regulation, poor storage stability, weak tolerance to gastric acid, pose an infection risk, and have insufficient development of stable products.
We developed a strain of Lactobacillus plantarum LPU3 and its inactivated, dead, and postbiotic forms, which, through various combinations, achieve multiple functions such as uric acid degradation, metabolic enzyme inhibition, intestinal flora improvement, and reduction of renal oxidative stress.
It provides multiple functions of uric acid degradation and metabolic enzyme inhibition, improves gut microbiota balance, reduces kidney oxidative stress induced by hyperuricemia, and enhances the storage stability and applicability of the strain.